RecruitingNot ApplicableNCT06392334
Mast Cells and Its Proteases in COPD
The Role of Mast Cells and Its Proteases in Chronic Obstructive Pulmonary Disease
Sponsor
Voronezh N.N. Burdenko State Medical Academy
Enrollment
30 participants
Start Date
Jan 29, 2019
Study Type
INTERVENTIONAL
Conditions
Summary
Mast cells proteases such as chymase and tryptase will be studied in the tissue of small and large airways in COPD patients
Eligibility
Min Age: 20 YearsMax Age: 70 Years
Plain Language Summary
Simplified for easier understanding
This observational study is examining the role of mast cells and their enzymes (proteases) in the lungs of people with COPD (chronic obstructive pulmonary disease). The goal is to better understand what drives inflammation in COPD to develop better treatments in the future.
**You may be eligible if...**
- You have been diagnosed with COPD
**You may NOT be eligible if...**
- You have another lung disease
- You have cancer
- You are pregnant
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERBiopsy
Biopsy of lung tissue
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06392334
Related Trials
Multidisciplinary Management of Severe COPD
NCT048603751 location
Predicting Adverse Outcomes Using Machine Learning of COPD Patients in Hong Kong
NCT058250141 location
Emotional-distress-based Integrated Care Programme in Patients With an Acute Exacerbation of COPD
NCT073519291 location
High-intensity Resistance Training in Post-exacerbation COPD
NCT073024251 location
DUET Versus Standard Interface for Hypercapnic COPD Patients
NCT058290832 locations